The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell–like properties through modulation of self-renewal signaling

Jisun Oh, Hyo‐Jin Yoon, Jeong‐Hoon Jang, Do‐Hee Kim, Young‐Joon Surh

Journal of Ginseng Research · 2018 · 48 citations · 41 references

DOIFull text

Open access

Abstract

This study suggests that Rg3 has a therapeutic potential targeting breast cancer stem cells.

References

41